Corcept Therapeutics | CORT - Devedores Comerciais

Preço das Ações
50.81
Mudança Diária
-0.39 -0.76%
Mensal
17.34%
Anual
-28.02%
Q2 Previsão
51.20




Devedores Comerciais Alterar Data
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Alaunos Therapeutics USD 2K 0 2025-06
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Ardelyx USD 71.85M 4.76M 2025-12
Assertio Holdings USD 39.91M 2.7M 2024-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Esperion Therapeutics USD 140.19M 21.21M 2025-12
J&J USD 21.33B 3.72B 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novartis USD 12.29B 3.3B 2025-12
Omeros USD 8.08M 440K 2024-06
Pacira USD 125.64M 1.57M 2026-03
Pfizer USD 16.17B 332M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
TG Therapeutics USD 392.05M 86.42M 2026-03